Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey.

PMID: 37653408
Journal: Orphanet Journal of Rare Diseases
Year: 2023
Reference: Orphanet J Rare Dis. 2023 Aug 31;18(1):257. doi: 10.1186/s13023-023-02869-1.
Impact factor:
Publication type: Paper in international publication
Authors: Chroscinska-Krawczyk, Magdalena; Chroscinska-Krawczyk, Magdalena; Cwyl, Maciej; Escolar, Maria Luisa; Jurecka, Agnieszka; Klopstock, Thomas; Klucken, Angelika; Lopez, Antonio; Lopez, Antonio; Mercimek-Andrews, Saadet et al.
DOI: 10.1186/s13023-023-02869-1

Patient Reported Outcomes following Cancer of the Rectum (PROCaRe): protocol of a prospective multicentre international study.

PMID: 37770748
Journal: Techniques in Coloproctology
Year: 2023
Reference: Tech Coloproctol. 2023 Sep 28. doi: 10.1007/s10151-023-02865-4.
Impact factor:
Publication type: Paper in international publication
Authors: Arredondo, Jorge; Pastor, Carlos; Pata, Francesco; Pellino, Gianluca; Pellino, Gianluca; Tejedor, Patricia et al.
DOI: 10.1007/s10151-023-02865-4

Patient with adrenal insufficiency due to a de novo mutation in the NR0B1 gene.

PMID: 38075942
Journal: Advances in Laboratory Medicine
Year: 2023
Reference: Adv Lab Med. 2023 Mar 15;4(2):195-202. doi: 10.1515/almed-2023-0018. eCollection 2023 Jun.
Impact factor:
Publication type: Paper in international publication
Authors: Arias Garcia, Andrea; Arnaiz, Marina Giralt; Bravo Nieto, Daniel; Campos Martorell, Ariadna; Clemente Leon, Maria; Diaz Troyano, Noelia; Fernandez Alvarez, Paula; Ferrer Costa, Roser; Garcia Fernandez, Alba S et al.
DOI: 10.1515/almed-2023-0018

Patient-centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA-EAACI approach.

PMID: 37042071
Journal: ALLERGY
Year: 2023
Reference: Allergy. 2023 Apr 11. doi: 10.1111/all.15740.
Impact factor:
Publication type: Review in international publication
Authors: Amaral, Rita; Ansotegui, Ignacio J; Anto, Josep M; Barbara, Cristina; Bedbrook, Anna; Bergmann, Karl C; Bewick, Michael; Blain, Hubert; Bonini, Matteo; Bosnic-Anticevich, Sinthia et al.
DOI: 10.1111/all.15740

Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC.

PMID: 37954964
Journal: JTO clinical and research reports
Year: 2023
Reference: JTO Clin Res Rep. 2023 Sep 9;4(11):100572. doi: 10.1016/j.jtocrr.2023.100572. eCollection 2023 Nov.
Impact factor:
Publication type: Paper in international publication
Authors: Awad, Mark M; Cheema, Parneet K; Csoszi, Tibor; Garcia-Alamino, Josep Maria; Gottfried, Maya; Gumus, Mahmut; Kalemkerian, Gregory P; Kato, Terufumi; Kim, Hye Ryun; Lopez-Cano, Manuel et al.
DOI: 10.1016/j.jtocrr.2023.100572

Patient-reported outcome measures and surgery for Crohn's disease: systematic review.

PMID: 37882628
Journal: BJS Open
Year: 2023
Reference: BJS Open. 2023 Sep 5;7(5):zrad098. doi: 10.1093/bjsopen/zrad098.
Impact factor:
Publication type: Paper in international publication
Authors: Alarcon Guitierrez, Miguel; Barbera, Maria Jesus; Celentano, Valerio; de Olalla, Patricia Garcia; Fuertes, Irene; Gallostra, Marc Marti; Iskandarani, Mohamad; Jacques-Avino, Constanza; Kim, Whei J; Kontovounisios, Christos et al.
DOI: 10.1093/bjsopen/zrad098

Patterns of inflammation, microstructural alterations, and sodium accumulation define multiple sclerosis subtypes after 15 years from onset.

PMID: 37035717
Journal: Frontiers in Neuroinformatics
Year: 2023
Reference: Front Neuroinform. 2023 Mar 23;17:1060511. doi: 10.3389/fninf.2023.1060511. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Alexander, Daniel C; Brownlee, Wallace; Ciccarelli, Olga; Gandini Wheeler-Kingshott, Claudia A M; Golay, Xavier; Grussu, Francesco; Kanber, Baris; Prados, Ferran; Ricciardi, Antonio; Riemer, Frank et al.
DOI: 10.3389/fninf.2023.1060511

Patterns of response to anti-calcitonin gene-related peptide monoclonal antibodies during first 6 months of treatment in resistant migraine patients: Impact on outcome.

PMID: 37038303
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2023
Reference: Eur J Neurol. 2023 Jul;30(7):1937-1944. doi: 10.1111/ene.15816. Epub 2023 Apr 26.
Impact factor:
Publication type: Paper in international publication
Authors: Alpuente, Alicia; Caronna, Edoardo; Gallardo, Victor J; Gine-Cipres, Eulalia; Pozo-Rosich, Patricia; Torres-Ferrus, Marta et al.
DOI: 10.1111/ene.15816

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.

PMID: 37871604
Journal: LANCET
Year: 2023
Reference: Lancet. 2023 Oct 19:S0140-6736(23)02033-0. doi: 10.1016/S0140-6736(23)02033-0.
Impact factor:
Publication type: Paper in international publication
Authors: Albillos, Agustin; Ampuero, Javier; Andrade, Raul J; Angeli, Paolo; Arroyo, Vicente; Bai, Yuxian; Ballester, Maria Pilar; Belli, Luca; Berenguer, Marina; Berg, Thomas et al.
DOI: 10.1016/S0140-6736(23)02033-0

Perceptions of Food among College Students in the Field of Food Science: A Food Sustainability Approach.

PMID: 36900434
Journal: Foods
Year: 2023
Reference: Foods. 2023 Feb 21;12(5):917. doi: 10.3390/foods12050917.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilera, Mari; Celorio-Sarda, Ricard; Comas-Baste, Oriol; de Moraes Prata Gaspar, Maria Clara; Gomez, Maria Clara; Larrea-Killinger, Cristina; Soar, Claudia; Vidal-Carou, M Carmen et al.
DOI: 10.3390/foods12050917

Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.

PMID: 37379158
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2023
Reference: N Engl J Med. 2023 Jun 28. doi: 10.1056/NEJMoa2215530.
Impact factor:
Publication type: Paper in international publication
Authors: Aguado de la Rosa, Carlos; Aguilar, Andres; Barneto, Isidoro; Benitez, Raquel; Bernabe, Reyes; Bosch-Barrera, Joaquim; Calvo, Virginia; Camps, Carlos; Casal-Rubio, Joaquin; Cobo, Manuel et al.
DOI: 10.1056/NEJMoa2215530

Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.

PMID: 37386897
Journal: BRITISH JOURNAL OF HAEMATOLOGY
Year: 2023
Reference: Br J Haematol. 2023 Jun 30. doi: 10.1111/bjh.18941.
Impact factor:
Publication type: Paper in international publication
Authors: Baeza, Lourdes; Borrero, Juan Jose; Castellvi, Josep; Climent, Fina; Cordoba, Raul; Domingo-Domenech, Eva; Fraga, Maximo; Garcia-Cosio Piqueras, Monica; Gomez Codina, Jose; Gonzalez de Villambrosia, Sonia et al.
DOI: 10.1111/bjh.18941

PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphoma.

PMID: 38024636
Journal: EJHaem
Year: 2023
Reference: EJHaem. 2023 Sep 11;4(4):1081-1088. doi: 10.1002/jha2.757. eCollection 2023 Nov.
Impact factor:
Publication type: Paper in international publication
Authors: Abrisqueta, Pau; Balaguer-Montero, Maria; Barba, Pere; Bobillo, Sabela; Bosch, Francesc; Carpio, Cecilia; Clark, Joan; Cooper, Nichola; Ghanima, Waleed; Haenig, Jens et al.
DOI: 10.1002/jha2.757

Pharmacoepidemiology: An Overview.

PMID: 38002647
Journal: Journal of Clinical Medicine
Year: 2023
Reference: J Clin Med. 2023 Nov 10;12(22):7033. doi: 10.3390/jcm12227033.
Impact factor:
Publication type: Paper in international publication
Authors: Blasi, Joan; Bong, David A; Coronel, Luis; D'Agostino, Maria Antonietta; Mandl, Peter; Martinoli, Carlo; Miguel-Perez, Maribel; Moller, Ingrid; Montane, Eva; Sabate, Monica et al.
DOI: 10.3390/jcm12227033

Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients With Mixed Solid Tumors (GO30103).

PMID: 38105505
Journal: JOURNAL OF CLINICAL PHARMACOLOGY
Year: 2023
Reference: J Clin Pharmacol. 2023 Dec 17. doi: 10.1002/jcph.2397.
Impact factor:
Publication type: Paper in international publication
Authors: Bedard, Philippe L; Calvo, Emiliano; Cervantes, Andres; Cho, Byoung Chul; Delord, Jean-Pierre; Ding, Hao; Garralda, Elena; Hendricks, Robert; Italiano, Antoine; Kim, Tae Won et al.
DOI: 10.1002/jcph.2397

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes.

PMID: 37776843
Journal: LEUKEMIA RESEARCH
Year: 2023
Reference: Leuk Res. 2023 Sep 20;134:107390. doi: 10.1016/j.leukres.2023.107390.
Impact factor:
Publication type: Paper in international publication
Authors: Alfonso-Pierola, Ana; Avivi, Irit; Brown, Regina J; Brunner, Andrew M; Cadenas, Felix Lopez; Chromik, Joerg; Falantes, Jose; Germing, Ulrich; Gu, Junchen; Haque, Tamanna et al.
DOI: 10.1016/j.leukres.2023.107390

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.

PMID: 36999533
Journal: HEPATOLOGY
Year: 2023
Reference: Hepatology. 2023 Sep 1;78(3):758-770. doi: 10.1097/HEP.0000000000000365. Epub 2023 Apr 1.
Impact factor:
Publication type: Paper in international publication
Authors: Azad, Nilofer; Bajars, Marcis; Borad, Mitesh J; Bridgewater, John; Cubillo, Antonio; de Braud, Filippo; Furuse, Junji; Hijioka, Susumu; Javle, Milind M; Kim, Jin Won et al.
DOI: 10.1097/HEP.0000000000000365

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.

PMID: 37870969
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2023
Reference: N Engl J Med. 2023 Oct 21. doi: 10.1056/NEJMoa2309719.
Impact factor:
Publication type: Paper in international publication
Authors: Adam-Artigues, Anna; Arenas, Enrique J; Arribas, Joaquin; Bardet, Stephane; Brose, Marcia S; Capdevila, Jaume; Cejalvo, Juan Miguel; Elisei, Rossella; Fuhrer, Dagmar; Gao, Ming et al.
DOI: 10.1056/NEJMoa2309719

Phase Ia/b Study of Giredestrant +/-Palbociclib and +/-Luteinizing Hormone-releasing Hormone Agonists in Estrogen Receptor-positive, HER2-negative, Locally Advanced/Metastatic Breast Cancer.

PMID: 37921755
Journal: CLINICAL CANCER RESEARCH
Year: 2023
Reference: Clin Cancer Res. 2023 Nov 3. doi: 10.1158/1078-0432.CCR-23-1796.
Impact factor:
Publication type: Paper in international publication
Authors: Bardia, Aditya; Bellet-Ezquerra, Meritxell; Bond, John W; Boni, Valentina; Buti, Maria; Casado, Miguel Angel; Chang, Ching-Wei; Dominguez-Hernandez, Raquel; Eng-Wong, Jennifer; Esteban, Rafael et al.
DOI: 10.1158/1078-0432.CCR-23-1796

Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).

PMID: 38102226
Journal: BRITISH JOURNAL OF CANCER
Year: 2023
Reference: Br J Cancer. 2023 Dec 15. doi: 10.1038/s41416-023-02513-6.
Impact factor:
Publication type: Paper in international publication
Authors: Aldecoa, Iban; Castellano, Daniel; Climent, Miguel A; Fernandez, Pedro L; Font, Albert; Gibson, Neil; Gonzalez-Del-Alba, Aranzazu; Jares, Pedro; Lorence, Robert M; Mellado, Begona et al.
DOI: 10.1038/s41416-023-02513-6

Physical activity and exercise for the prevention and management of mild cognitive impairment and dementia: a collaborative international guideline.

PMID: 37768499
Journal: European Geriatric Medicine
Year: 2023
Reference: Eur Geriatr Med. 2023 Sep 28. doi: 10.1007/s41999-023-00858-y.
Impact factor:
Publication type: Paper in international publication
Authors: Alves, Mariana; Ars, Joan; Ars, Joan; Bahat, Gulistan; Barbagallo, Mario; Barbagallo, Mario; Bauer, Jurgen; Bautman, Ivan; Bazan, Laura Monica Perez; Brugiavini, Agar et al.
DOI: 10.1007/s41999-023-00858-y

Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.

PMID: 36921693
Journal: ANNALS OF ONCOLOGY
Year: 2023
Reference: Ann Oncol. 2023 Jun;34(6):543-552. doi: 10.1016/j.annonc.2023.02.016. Epub 2023 Mar 14.
Impact factor:
Publication type: Paper in international publication
Authors: Antista, M; Baraibar, I; Boccaccino, A; Comas, R; Cremolini, C; Dientsmann, R; Elez, E; Garcia, A; Martin, A; Martinelli, E et al.
DOI: 10.1016/j.annonc.2023.02.016

Platelet Analysis in the Thrombus Plus Serum BNP for Detecting Clot-Related Atrial Fibrillation. Results From the ITACAT Multicentric Registry.

PMID: 38091189
Journal: Translational Stroke Research
Year: 2023
Reference: Transl Stroke Res. 2023 Dec 13. doi: 10.1007/s12975-023-01220-x.
Impact factor:
Publication type: Paper in international publication
Authors: Camacho, Jessica; de-la-Torre, Carolina; Dorado, Laura; Garcia-Tornel, Alvaro; Hernandez, David; Hernandez-Perez, Maria; Juega, Jesus; Lazaro, Carlos; Molina, Carlos; Muchada, Marian et al.
DOI: 10.1007/s12975-023-01220-x

Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.

PMID: 37434063
Journal: Advanced Science
Year: 2023
Reference: Adv Sci (Weinh). 2023 Jul 11:e2300299. doi: 10.1002/advs.202300299.
Impact factor:
Publication type: Paper in international publication
Authors: Acurcio, Rita C; Afonso, Marta B; Arango, Diego; Carreira, Barbara; Florindo, Helena F; Gois, Pedro M P; Graca, Luis; Jordan, Rainer; Martinez-Barriocanal, Agueda; Matos, Ana I et al.
DOI: 10.1002/advs.202300299

Publications